GeoVax Labs, Inc. (NASDAQ:GOVXW – Get Free Report)’s share price dropped 14.1% on Wednesday . The company traded as low as $0.10 and last traded at $0.10. Approximately 19,999 shares were traded during trading, a decline of 8% from the average daily volume of 21,681 shares. The stock had previously closed at $0.12.
GeoVax Labs Stock Performance
The stock has a 50 day simple moving average of $0.12 and a 200 day simple moving average of $0.15.
About GeoVax Labs
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.
Featured Articles
- Five stocks we like better than GeoVax Labs
- Trading Stocks: RSI and Why it’s Useful
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Financial Services Stocks Investing
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- 3 Healthcare Dividend Stocks to Buy
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.
